Search Within

Dmitry D. Pankov

Formats
  1. Journal Article (15)
  2. Meeting Abstract (7)
Groups
  1. Sloan Kettering Institute Postdocs (22)
  2. GSK Faculty (21)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (20)
  4. Department of Medicine (20)
  5. Sloan Kettering Institute Faculty (19)
  6. Tow Center for Developmental Oncology (TCDO) (19)

More Groups

People
  1. Richard O'Reilly (14)
  2. Tao Dao (11)
  3. David Scheinberg (10)
  4. Ekaterina Doubrovina (9)
  5. Leonid Dubrovsky (8)
  6. Nicholas Veomett (6)

More People

Years
  1. 2024 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2018 (1)
  5. 2017 (2)
  6. 2016 (4)

More Years

Publications
  1. Blood (5)
  2. Clinical Cancer Research (3)
  3. OncoImmunology (3)
  4. Biology of Blood and Marrow Transplantation (2)
  5. Cancer Cell (1)
  6. Cancer Immunology Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Society of Hematology (5)
  3. Elsevier Inc. (3)
  4. Landes Bioscience (3)
  5. Amer Soc Clinical Investigation Inc (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic activity of a bi-specific T cell engaging, TCR-mimic monoclonal antibody to WT1 against human leukemias and cancers in mouse models
    Meeting Abstract

    Pankov, D.; Dao, T.; Dubrovsky, L.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
    Journal Article

    Dao, T.; Pankov, D.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Xu, Y.; Xiang, J.; Yan, S. ; Direito de Morais Guerreiro, M.; Veomett, N.; more...
    Nature Biotechnology (2015)

    Fulltext@MSK | Save
  • CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
    Journal Article

    Meyer, S.; Keller, M.; Chiu, S.; Koppikar, P.; Guryanova, O.; Rapaport, F.; Xu, K.; Manova, K.; Pankov, D.; O'reilly, R.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein
    Journal Article

    Veomett, N.; Dao, T.; Liu, H.; Xiang, J.; Pankov, D.; Dubrovsky, L.; Whitten, J. A.; Park, S. M.; Korontsvit, T.; Zakhaleva, V.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias
    Journal Article

    Dubrovsky, L.; Pankov, D.; Brea, E. J.; Dao, T.; Scott, A.; Yan, S.; O'Reilly, R. J.; Liu, C.; Scheinberg, D. A.
    Blood (2014)

    Fulltext@MSK | Save
  • A bi-specific T cell engaging monoclonal antibody (mAb) derived from a TCR-Like mAB specific for WT1/HLA-A0201 (ESK-BiTE) shows a potent activity against human AML and Ph+ ALL in mouse models
    Meeting Abstract

    Pankov, D.; Dao, T.; Wang, Y.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Veomett, N.; Curcio, M.; Doubrovina, E.; O'Reilly, R. J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Therapeutic efficacy and cure of sensitive and T315I pan-resistant human Ph+ leukemia in mice using a TCR-like antibody to WT1/HLA-A0201 alone, or in combination with tyrosine kinase inhibitors
    Meeting Abstract

    Dubrovsky, L.; Brea, E.; Pankov, D.; Veomett, N.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
    Blood (2013)

    Fulltext@MSK | Save
  • Targeting the intracellular WT1 oncogene product with a therapeutic human antibody
    Journal Article

    Dao, T.; Yan, S. ; Veomett, N.; Pankov, D.; Zhou, L.; Korontsvit, T.; Scott, A.; Whitten, J.; Maslak, P.; Casey, E.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias
    Journal Article

    Doubrovina, E.; Carpenter, T.; Pankov, D.; Selvakumar, A.; Hasan, A.; O'Reilly, R. J.
    Blood (2012)

    Fulltext@MSK | Save
  • WT1 specific T cells can efficiently eliminate tumorigenic ovarian carcinoma cells and prevent or inhibit the tumor growth in NOD/SCID model of ovarian carcinoma
    Meeting Abstract

    Pankov, D.; O'Reilly, R.; Doubrovin, M.; Hasan, A.; Doubrovina, E.
    Cancer Research (2011)

    Fulltext@MSK | Save